GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (FRA:AFX) » Definitions » EV-to-Revenue

Carl Zeiss Meditec AG (FRA:AFX) EV-to-Revenue : 4.35 (As of Apr. 27, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Carl Zeiss Meditec AG EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Carl Zeiss Meditec AG's enterprise value is €9,116 Mil. Carl Zeiss Meditec AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €2,094 Mil. Therefore, Carl Zeiss Meditec AG's EV-to-Revenue for today is 4.35.

The historical rank and industry rank for Carl Zeiss Meditec AG's EV-to-Revenue or its related term are showing as below:

FRA:AFX' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.8   Med: 4.23   Max: 11.06
Current: 4.36

During the past 13 years, the highest EV-to-Revenue of Carl Zeiss Meditec AG was 11.06. The lowest was 1.80. And the median was 4.23.

FRA:AFX's EV-to-Revenue is ranked worse than
62.45% of 823 companies
in the Medical Devices & Instruments industry
Industry Median: 3.02 vs FRA:AFX: 4.36

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-27), Carl Zeiss Meditec AG's stock price is €99.00. Carl Zeiss Meditec AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €23.45. Therefore, Carl Zeiss Meditec AG's PS Ratio for today is 4.22.


Carl Zeiss Meditec AG EV-to-Revenue Historical Data

The historical data trend for Carl Zeiss Meditec AG's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG EV-to-Revenue Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.45 7.29 9.17 4.92 3.62

Carl Zeiss Meditec AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.37 5.75 4.26 3.62 4.22

Competitive Comparison of Carl Zeiss Meditec AG's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's EV-to-Revenue falls into.



Carl Zeiss Meditec AG EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Carl Zeiss Meditec AG's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=9115.984/2094.039
=4.35

Carl Zeiss Meditec AG's current Enterprise Value is €9,116 Mil.
Carl Zeiss Meditec AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €2,094 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carl Zeiss Meditec AG  (FRA:AFX) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Carl Zeiss Meditec AG's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=99.00/23.45
=4.22

Carl Zeiss Meditec AG's share price for today is €99.00.
Carl Zeiss Meditec AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €23.45.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carl Zeiss Meditec AG EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG (FRA:AFX) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Carl Zeiss Meditec AG (FRA:AFX) Headlines

No Headlines